4//SEC Filing
Ruffo Frank 4
Accession 0001209191-22-006832
CIK 0001557746other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:46 PM ET
Size
7.0 KB
Accession
0001209191-22-006832
Insider Transaction Report
Form 4
Ruffo Frank
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-02-01+3,875→ 173,747 total - Exercise/Conversion
Restricted Stock Units
2022-02-01−3,875→ 0 total→ Common Stock (3,875 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The shares underlying these restricted stock units vested on February 1, 2022.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001654450
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:46 PM ET
- Size
- 7.0 KB